Physician profile
Mark Ryan Rowe
NPI 1770922510
$2,616.68
in general payments reported to CMS, 2019-2025
47 companies · $722 in 2025
The $722 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $187 · 2021: $527 · 2022: $426 · 2023: $289 · 2024: $465 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $322.65 | 2020-2025 | Airsupra, Tezspire |
| Inspire Medical Systems, INC. | $195.21 | 2023-2024 | Inspire |
| Novo Nordisk INC | $189.61 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $157.36 | 2020-2025 | Otezla, Repatha, Otezla |
| Abbvie INC. | $120.55 | 2021-2025 | |
| Boston Scientific Corporation | $97.40 | 2022-2025 | Wavewriter Alpha Prime 16, Accolade Sr |
| Exact Sciences Corporation | $91.09 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $83.64 | 2021-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $76.70 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $60.81 | 2025 | Keveyis, Gvoke Hypopen |
| Paratek Pharmaceuticals, INC. | $57.92 | 2021 | |
| Hologic Sales and Service, LLC | $56.45 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Alexion Pharmaceuticals, INC. | $54.50 | 2020-2022 | |
| Edwards Lifesciences Corporation | $53.73 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $50.04 | 2021-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.